Envair Electrodyne Reports Mixed Q2 FY26 Results with Profit Decline and Asset Growth
Envair Electrodyne Limited announced its Q2 and H1 FY26 results, showing a significant 84% decline in quarterly profit to ₹3.20 crore from ₹20.47 crore in Q2 FY25. However, the company's balance sheet improved with total assets increasing to ₹900.44 crore and cash position strengthening to ₹10.67 crore. Short-term borrowings were eliminated, and total equity rose to ₹848.14 crore. The Board approved these results on November 13, 2025.

*this image is generated using AI for illustrative purposes only.
Envair Electrodyne Limited has announced its unaudited financial results for the second quarter and half year ended September 30, 2025. The company's performance shows a mixed picture with a decline in profits but growth in assets and equity.
Financial Performance
The company reported the following key financial metrics:
| Metric | Q2 FY26 | Q2 FY25 | H1 FY26 | H1 FY25 |
|---|---|---|---|---|
| Profit from ordinary activities before exceptional items | ₹3.20 | ₹20.47 | - | - |
| Profit before tax | - | - | ₹20.47 | ₹37.81 |
The figures indicate a significant decline in quarterly profit, with Q2 FY26 profit falling by about 84% compared to the same quarter last year.
Balance Sheet Highlights
As of September 30, 2025, the company's financial position shows some improvements:
| Metric | September 30, 2025 | March 31, 2025 |
|---|---|---|
| Total Assets | ₹900.44 | ₹888.29 |
| Cash and Cash Equivalents | ₹10.67 | ₹3.73 |
| Short-term Borrowings | ₹0.00 | ₹2.40 |
| Total Equity | ₹848.14 | ₹827.67 |
The company has seen an increase in total assets and a significant improvement in cash position. Notably, Envair Electrodyne has eliminated its short-term borrowings, which stood at ₹2.40 lakhs in March 2025.
Board Approval and Disclosure
The Board of Directors approved these results in a meeting held on November 13, 2025. The meeting commenced at 01:45 PM and concluded at 02:40 PM. The company has submitted these results in compliance with Regulation 33 and other applicable regulations of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Conclusion
While Envair Electrodyne faces challenges with declining profits, the company has shown improvements in its balance sheet, particularly in asset growth and debt reduction. The company's strategies to improve profitability in the coming quarters may be of interest to investors and stakeholders.
Historical Stock Returns for Envair Electrodyne
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.08% | +1.54% | +3.99% | -19.80% | -45.27% | +204.05% |




























